Last Update Time:
13-Mar-2025 12:59:50
ISIN:
INE829A01014
Sector:
Healthcare
Symbol:
BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Limited
₹44.48
₹0.27
(0.61%)
▲
Prev. Close
₹44.21
Open
₹44.52
Close
₹0.00
Range
₹42.26 - ₹46.70
High
₹46.69
Low
₹42.95
Ind. Close
₹0.00
VWAP
₹43.96
The current stock price of Biofil Chemicals & Pharmaceuticals Limited is ₹44.48, with a target price range between ₹42.26 and ₹46.70. The stock has experienced a price change of ₹0.27 (0.61%), reflecting recent market volatility.
Today's opening price was ₹44.52, while the previous close stood at ₹44.21.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Biofil Chemicals & Pharmaceuticals Limited Price Chart
Biofil Chemicals & Pharmaceuticals Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 0
- Previous Close Price: 44.21
- Change: -44.21%
- Total Traded Volume: 0
- Total Buy Quantity: 11,519
- Total Sell Quantity: 8,017
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 0.00 | 0.00 | 0.00 |
| 43.00 | 2.00 | 0.00 |
| 43.10 | 3.00 | 0.00 |
| 43.80 | 8.00 | 0.00 |
| 44.00 | 129.00 | 0.00 |
| 45.21 | 0.00 | 100.00 |
| 45.29 | 0.00 | 2.00 |
| 45.75 | 0.00 | 99.00 |
| 45.79 | 0.00 | 42.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 43.54 | 1 | 44.48 | 2 |
| 43.53 | 4 | 44.49 | 5 |
| 43.51 | 1 | 44.50 | 100 |
| 43.50 | 10 | 44.59 | 1 |
| 43.32 | 2 | 44.68 | 5 |
Total Buy Quantity: 11519
Total Sell Quantity: 8017
Shareholding Patterns of Biofil Chemicals & Pharmaceuticals Limited
Key Trade Statistics of Biofil Chemicals & Pharmaceuticals Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.20 |
| Traded Value (₹ Cr.) | 0.09 |
| Total Market Cap (₹ Cr.) | 72.39 |
| Free Float Market Cap (₹ Cr.) | 38.50 |
| Impact cost | 0.68 |
| Quantity Traded | 11,018.00 |
| Deliverable Quantity | 8,160.00 |
| % of Quantity to Traded | 74.06 |
| Security VaR | 21.88 |
| Index VaR | N/A |
| VaR Margin | 21.88 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 25.38 |
| Face Value | 10 |
Key Price Statistics of Biofil Chemicals & Pharmaceuticals Limited
The 52-week high for Biofil Chemicals & Pharmaceuticals Limited was ₹91.87, recorded on 16-Sep-2024. On the other hand, the 52-week low stands at ₹42.00, with the lowest value recorded on 03-Mar-2025.
The upper band for trading is ₹53.05, and the lower band is ₹35.36. The price band is 20%.
The stock's daily volatility stands at 3.31, while the annualized volatility is 63.24. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (16-Sep-2024) | 91.87 |
| 52 Week Low (03-Mar-2025) | 42.00 |
| Upper Band | 53.05 |
| Lower Band | 35.36 |
| Price Band (%) | 20 |
| Daily Volatility | 3.31 |
| Annualised Volatility | 63.24 |
| Tick Size | 0.01 |
Key Securities Statistics of Biofil Chemicals & Pharmaceuticals Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 12-Jun-1996 |
| Adjusted P/E | 118.55 |
| Symbol P/E | 118.55 |
| Index | NA |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Biofil Chemicals & Pharmaceuticals Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Biofil Chemicals & Pharmaceuticals Limited
| Subject | Date |
|---|---|
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 11-Mar-2025 |
| Change in Management | 11-Mar-2025 |
| Demise | 11-Mar-2025 |
| Updates | 19-Feb-2025 |
| Copy of Newspaper Publication | 18-Feb-2025 |
| Updates | 17-Feb-2025 |
| Notice Of Shareholders Meetings-XBRL | 17-Feb-2025 |
| Shareholders meeting | 17-Feb-2025 |
Corporate Actions of Biofil Chemicals & Pharmaceuticals Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Annual General Meeting | 23-Sep-2024 |
| 10 | Annual General Meeting | 20-Sep-2023 |
| 10 | Annual General Meeting | 21-Sep-2022 |
| 10 | Annual General Meeting | 17-Sep-2021 |
| 10 | Annual General Meeting | 21-Sep-2020 |
| 10 | Annual General Meeting | 18-Sep-2019 |
| 10 | Annual General Meeting | 18-Sep-2018 |
| 10 | Annual General Meeting | 14-Sep-2017 |
| 10 | Annual General Meeting | 22-Sep-2016 |
| 10 | Annual General Meeting | 16-Sep-2015 |
| 10 | Annual General Meeting | 18-Sep-2014 |
| 10 | Annual General Meeting | 19-Sep-2013 |
| 10 | Annual General Meeting | 20-Sep-2012 |
| 10 | Annual General Meeting | 22-Sep-2011 |
| 10 | Annual General Meeting | 23-Sep-2009 |
| 10 | Annual General Meeting | 19-Sep-2008 |
| 10 | Agm | 20-Sep-2007 |
| 10 | Agm | 21-Sep-2006 |
| 10 | Agm | 22-Sep-2005 |
Board Meetings of Biofil Chemicals & Pharmaceuticals Limited
Financial Results of Biofil Chemicals & Pharmaceuticals Limited
Company Directory of Biofil Chemicals & Pharmaceuticals Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.biofilgroup.net | Head Office/ Corporate Office | B-12/B Industrial Estate Pologround | INDORE |
| www.biofilgroup.net | Registered Office | 11/12, SECTOR E SANWER ROAD INDUSTRIAL AREA | INDORE |
| www.biofilgroup.net | Transfer Agent | Ankit Consultancy Pvt Ltd 60, Electronic Complex, Pardeshipura | INDORE |
Insider Trading of Biofil Chemicals & Pharmaceuticals Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | SANDEEP SHAH | 0 | Sell |
| 7(2) | MANALI SIMON | 0 | Buy |
| 7(2) | Niyati Shah | 0 | Buy |
| 7(2) | RAMESH SHAH | 0 | Sell |
| 7(2) | MEENA SHAH | 0 | Buy |
| 7(2) | RAMESH SHAH | 1406200 | Buy |
Annual Reports of Biofil Chemicals & Pharmaceuticals Limited
Investor Complaints of Biofil Chemicals & Pharmaceuticals Limited
Event Calendar of Biofil Chemicals & Pharmaceuticals Limited
| Purpose | Details |
|---|---|
| Results/Others | To consider and approve the Audited Financial Result for the Quarter as well as year ended March 31, 2011 along with other routine business. |
| Results/Others | To take on record the Un-audited Financial Results of the Company for the quarter ended on June 30, 2011 alongwith other routine business. |
| Results/Others | To take on record the Un-audited Financial Results of the Company for the quarter ended on September 30, 2011 alongwith other routine business. |
| Results/Others | To consider and approve the Audited Financial Result for the Quarter as well as year ended March 31, 2012 along with other routine business. |
| Results/Others | To take on record and approve the Un-audited Financial Results of the Company for the quarter ended on September 30, 2012 along with other routine business. |
| Results/Others | To take on record and approve the Un-audited Financial Results of the Company for the quarter ended on June 30, 2013 along with other routine business. |
| Results/Others | To take on record and approve the Un-audited Financial Results of the Company for the quarter ended on September 30, 2013 along with other routine business. |
| Results | To take on record the Un-audited Financial Results of the Company for the quarter ended on December 31, 2013 along with other routine business. |
| Results/Others | To transact the following matters along with other routine matters: 1) To consider and approve the Audited Financial Results for the Quarter as well as year ended March 31, 2014. 2) Any other matter with the permission of the chair. Further, in terms of provisions of the Company's Code of Conduct for Prevention of Insider Trading (Code), the "Trading Window" for trading in the equity shares of the Company shall remain closed from May 16, 2014 to June 02, 2014, for all the designated employees and Directors of the Company for the purpose approval quarterly as well Annual financial statement. |
| Results/Others | To take on record and approve the following matters: 1.Un-audited Financial Results of the Company for the quarter ended June 30, 2014. 2. To consider and fix the Notice of Annual General Meeting and Book closure date for the financial year ended March 31, 2014. 3. To fix the cut-off date to record the entitlement of the shareholders to cast their vote electronically at the ensuing AGM by electronic means under the Companies Act, 2013 and rules made there under. Further, in terms of provisions of the Company's Code of Conduct for Prevention of Insider Trading (Code) the "Trading Window" for trading in equity shares of the Company shall remain closed from August 4, 2014 to August 15, 2014 for all the Designated employees and Directors of the Company for the purpose approval quarterly financial statement for the quarter ended June 30, 2014. |
| Results | To take on record and approve the following matters : 1.Un-audited Financial Results of the Company for the quarter ended September 30, 2014. |
| Results | To take on record and approve the following matters : 1. Un-audited Financial Results of the Company for the quarter ended on December 31, 2014. |
| Results | To take on record and approve the following matter: 1. Audited Financial Results of the Company for the Quarter as well as financial year ended March 31, 2015. |
| Results/Others | To transact the following matters along with other routine matters:1. To consider and approve the Un-Audited Quarterly Financial Result for the Quarter ended June 30, 2015 .2. To consider and approval of Board's Report.3. To fix time, date & venue of 30th Annual General Meeting of the company for the financial year ended on March 31, 2015.4. To fix date of Book closure for the purpose of 30th Annual General Meeting.5. To fix cut-off date for the purpose of members eligible for Remote E-voting and voting at the time of 30th Annual General Meeting6. To appoint Scrutinizer for the process of Remote E-voting as well as voting at the AGM.7. To appoint internal auditor.8. Any other matter with the permission of the chair. |
| Results/Others | to transact the following matters along with other routine matters:1) To consider and approve the Un-Audited Quarterly Financial Result for the Quarter ended September 30, 2015.2) Any other matter with the permission of the chair. |
| Results/Others | (1)To Consider and approve the Unaudited financial Results for the quarter ended on 31st December,2015 along with Limited Review Reoprt.(2) To consider and accept the resignation letter from existing Company Secretary and Compliance officer and appointment of new Company Secretary and compliance officer in place of existing Company secretary and Compliance officer.(3) Any other matter with the permission of the Chair. |
| Results | To transact the following matters: (1) To consider and approve, Standalone Audited Financial Results for the Quarter / Financial Year ended on March 31, 2016 along with Auditors Report thereon.(2) Any other matter with the permission of the chair.. |
| Results/Others | To transact the following matters:-1. To consider and approve the un-audited financial Result for the 1st Quarter ended on June 30, 2016 along with limited review report.2: To consider and approve Boards Report.3. To fix time, date and venue of Annual General Meeting of the Company for the financial year ended on March 31, 20164. To fix date of Book Closure for the purpose of Annual General Meeting.5. To fix cut off date for the purpose of members eligible for remote e voting and voting at the AGM.6. To appoint Scrutinizer for the process of Remote Evoting and voting at the AGM. |
| Results/Others | to transact the following matters :- 1. to consider and approve the un audited financial results for the second quarter ended on September 30, 2016 along with limited review report. 2. Any other matter with the permission of the Chair. |
| Results/Others | To transact the following matters:- 1. To consider and approve the un-audited financial result for the 3rd Quarter ended on December 31, 2016 along with limited review report. 2. Any other matter with the permission of the Chair. |
| Results/Others | to consider and approve the following businesses with the permission of the Chair: 1) To consider and approve Standalone Audited Financial Results for the Quarter as well as Year ended on March 31, 2017 along with Auditors Report thereon. 2) Any other routine businesses with the permission of the chair. |
| Results/Others | to transact the following matters:-1) To consider and approve the Un audited Financial Result of the Company for the Quarter ended on June 30, 2017 along with limited review report.2) To consider and approve Board's Report along with Corporate Governance Report and Management Discussion and Analysis Report for the year ended on March 31, 2017.3) To fix day, date time & venue of Annual General Meeting of the Company for the financial year ended on March 31, 2017 and approve the draft Notice of Annual General Meeting.4) To fix date of Book Closure for the purpose of Annual General Meeting.5) To fix cut-off date for the purpose of members eligible for Remote E-voting and voting at the time of Annual General Meeting.6) To appoint Scrutinizer for the process of Remote E voting as well as voting at theAnnual General Meeting.7) To appoint M/s. Maheshwari & Gupta, Chartered Accountant s, Indore (ICAI Firm Registration Number 006179C) as Statutory Auditors of the Company recommended by audit committee subject to approval of members in ensuing Annual General Meeting.8) Any other matter with the permission of the chair. |
| Results | To transact the following matters:- 1. To consider and approve the Un-audited Financial Result of the Company for the 2nd Quarter ended on September 30, 2017 along with limited review report. 2. Statement of Assets and Liabilities for the half year ended on 30th September 2017. 3. Any other matter with the permission of the chair. |
| Results/Others | to transact the following matters: 1) To consider and approve the Un-audited Financial Result of the Company for the 3rd Quarter ended on December 31, 2017 along with Limited Review Report. 2) Any other matter with the permission of the Chair. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results/Other business matters | to transact the following matters :-(1) To consider and approve the Un-financial results of the Company for the 1st Quarter ended on June 30, 2019 along with Limited Review Report.(2) Any other matter with the permission of the chair. |
| Financial Results/Other business matters | To transact the following matters:- 1. To consider and approve the Un-Audited Financial Results of the Company for the quarter as well as half year ended on September 30, 2019 along with statement of assets and liabilities and limited review report., 2. Any other matter with the permission of chair. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2021 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 30-May-2022 to consider financial statements for the period ended March 2022 |
| Financial results | Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 09-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve un-audited Financial Results for the quarter as well as nine months ended on 31st December, 2023 along with Limited Review Report thereon and to consider any other routine matters with the permission of Chair. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
Share Transfers of Biofil Chemicals & Pharmaceuticals Limited
Voting Results of Biofil Chemicals & Pharmaceuticals Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 30-SEP-2024 | AGM | To consider and adopt the Audited Financial Statements of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2024. |
| 30-SEP-2024 | AGM | Disposal of Undertaking situated at 11/12, Sector 'E', Sanwer Road Industrial Area, Indore ￢ﾀﾓ 452015 Madhya Pradesh to Cyano Pharma Private Limited, (Related Party) |
| 30-SEP-2024 | AGM | Approval for Loan, Guarantee or Investments in excess of the prescribed limits under Section 186 of the Companies Act, 2013 |
| 30-SEP-2024 | AGM | Approval of Material Related Party Transaction(s) with Cyano Pharma Private Limited |
| 30-SEP-2024 | AGM | To appoint a Director in place of Mr. Romil Shah (DIN: 00326110) who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible offers himself for re-appointment. |
| 15-MAR-2024 | Postal Ballot | DISPOSAL OF UNDERTAKING SITUATED AT 11/12, SECTOR 'E', SANWER ROAD INDUSTRIAL AREA, INDORE ￢ﾀﾓ 452015 MADHYA PRADESH |
| 27-SEP-2023 | AGM | TO CONSIDER AND ADOPT THE AUDITED FINANCIAL STATEMENT OF THE COMPANY TOGETHER WITH THE REPORT OF THE BOARD OF DIRECTORS AND THE AUDITORS THEREON FOR THE FINANCIAL YEAR ENDED MARCH 31, 2023 |
| 27-SEP-2023 | AGM | APPROVAL OF MATERIAL RELATED PARTY TRANSACTION(S) WITH CYANO PHARMA PRIVATE LIMITED |
| 27-SEP-2023 | AGM | APPOINTMENT OF MRS. GAYATRI PADIYAR (DIN: 10260173) AS A NON EXECUTIVE INDEPENDENT DIRECTOR OF THE COMPANY |
| 27-SEP-2023 | AGM | RE-APPOINTMENT OF MR. KETAN SHAH AS WHOLE TIME DIRECTOR OF THE COMPANY |
| 27-SEP-2023 | AGM | TO APPOINT A DIRECTOR IN PLACE OF MR. KETAN SHAH WHOLE TIME DIRECTOR OF THE COMPANY, WHO RETIRES BY ROTATION IN TERMS OF SECTION 152(6) OF THE COMPANIES ACT, 2013 AND BEING ELIGIBLE OFFERS HIMSELF FOR RE-APPOINTMENT |
| 30-SEP-2022 | AGM | To consider and adopt the Audited Financial Statement of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2022. |
| 30-SEP-2022 | AGM | APPROVAL OF MATERIAL RELATED PARTY TRANSACTION(S) WITH CYANO PHARMA PRIVATE LIMITED. |
| 30-SEP-2022 | AGM | RE-APPOINTMENT OF M/SMAHESHWARI & GUPTA, CHARTERED ACCOUNTANTS AS STATUTORY AUDITORSnOF THE COMPANY AND TO FIX THEIR REMUNERATION. |
| 30-SEP-2022 | AGM | To appoint a Director in place of Mr. Romil Shah (DIN: 00326110) Non executive Non Independent Director of the Company, who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible offers himself for re-appointment. |
| 27-SEP-2021 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2021, together with the Reports of the Board of Directors and Auditors thereon. |
| 27-SEP-2021 | AGM | Appointment of Mr. Satish Beohar (DIN: 09220291) as a Non Executive Independent Director of the Company. |
| 27-SEP-2021 | AGM | Re-appointment of Mr. Ramesh Shah (DIN: 00028819), as a Managing Director of the Company. |
| 27-SEP-2021 | AGM | To appoint a Director in place of Mr. Ketan Shah (DIN: 08818212), Whole-time Director who retires by rotation and being eligible offers himself for re-appointment. |
| 29-SEP-2020 | AGM | To receive, consider, approve and adopt the Audited Financial Statements of the Company for the financial year endedn31st March, 2020, together with the Reports of the Board of Directors and Auditors thereon |
FAQs on Biofil Chemicals & Pharmaceuticals Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.